{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:05:30Z","timestamp":1779257130303,"version":"3.51.4"},"reference-count":60,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5551\/jat.21246","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:44:00Z","timestamp":1384832640000},"page":"186-203","source":"Crossref","is-referenced-by-count":26,"title":["Rapid Development of Atherosclerosis in the World\u2019s Smallest Microminipig Fed a High-Fat\/High-Cholesterol Diet"],"prefix":"10.5551","volume":"21","author":[{"given":"Hiroaki","family":"Kawaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ayaori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Uto-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Ikegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jawien J: The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis. Curr Pharm Biotechnol, 2012; 13: 2435-2439","DOI":"10.2174\/138920112804583023"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M, Hofker MH: Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoE and ldlr mice. Clin Chem Lab Med, 2005; 43: 470-479","DOI":"10.1515\/CCLM.2005.085"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Getz GS, Reardon CA: Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol, 2012; 32: 1104-1115","DOI":"10.1161\/ATVBAHA.111.237693"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bilheimer DW, Watanabe Y, Kita T: Impaired receptormediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci U S A, 1982; 79: 3305-3309","DOI":"10.1073\/pnas.79.10.3305"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Brousseau ME, Hoeg JM: Transgenic rabbits as models for atherosclerosis research. J Lipid Res, 1999; 40: 365-375","DOI":"10.1016\/S0022-2275(20)32440-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fan J, Watanabe T: Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther, 2003; 99: 261-282","DOI":"10.1016\/S0163-7258(03)00069-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Forster R, Ancian P, Fredholm M, Simianer H, Whitelaw B: The minipig as a platform for new technologies in toxicology. J Pharmacol Toxicol Methods, 2010; 62: 227-235","DOI":"10.1016\/j.vascn.2010.05.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Goodrich JA, Clarkson TB, Cline JM, Jenkins AJ, Del Signore MJ: Value of the minipig model of menopause in the assessment of benefits and risks of postmenopausal therapies for cardiovascular and reproductive tissues. Fertil Steril, 2003; 79: 779-788","DOI":"10.1016\/S0015-0282(02)04826-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Turk JR, Henderson KK, Vanvickle GD, Watkins J, Laughlin MH: Arterial endothelial function in a porcine model of early-stage atherosclerotic disease. Int J Exp Pathol, 2005; 86: 335-345","DOI":"10.1111\/j.0959-9673.2005.00446.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhang C, Yin W, Liao D, Huang L, Tang C, Tsutsumi K, Wang Z, Liu Y, Li Q, Hou H, Cai M, Xiao J: NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs. J Lipid Res, 2006; 47: 2055-2063","DOI":"10.1194\/jlr.M600226-JLR200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Herrmann J, Saguner AM, Versari D, Peterson TE, Chade A, Olson M, Lerman LO, Lerman A: Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res, 2007; 101: 865-874","DOI":"10.1161\/CIRCRESAHA.107.152959"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takai H, Miyoshi A, Yamazaki M, Adachi K, Katagiri K, Arakawa H, Katsuyama K, Ito T, Fujii E, Hayashi S, Kato A, Suzuki M: Granulocyte colony-stimulating factor has no adverse effects on atherosclerotic lesions in high cholesterol-fed miniature Swine. J Vet Med Sci, 2008; 70: 943-950","DOI":"10.1292\/jvms.70.943"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kawaguchi H, Miyoshi N, Miura N, Fujiki M, Horiuchi M, Izumi Y, Miyajima H, Nagata R, Misumi K, Takeuchi T, Tanimoto A, Yoshida H: Microminipig, a non-rodent experimental animal optimized for life science research: Novel atherosclerosis model induced by high fat and cholesterol diet. J Pharmacol Sci, 2011; 115: 115-121","DOI":"10.1254\/jphs.10R17FM"},{"key":"14","unstructured":"14) Miyoshi N, Horiuchi M, Inokuchi Y, Miyamoto Y, Miura N, Tokunaga S, Fujiki M, Izumi Y, Miyajima H, Nagata R, Misumi K, Takeuchi T, Tanimoto A, Yasuda N, Yoshida H, Kawaguchi H: Novel microminipig model of atherosclerosis by high fat and high cholesterol diet, established in Japan. In Vivo, 2010; 24: 671-680"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Vergnes L, Phan J, Strauss M, Tafuri S, Reue K: Cholesterol and cholate cpomponents of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem, 2003; 278: 42774-42784","DOI":"10.1074\/jbc.M306022200"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 2004; 303: 1201-4120","DOI":"10.1126\/science.1093131"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L: Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest, 2007; 117: 1968-1978","DOI":"10.1172\/JCI30060"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kawaguchi H, Yamada T, Miura N, Takahashi Y, Yoshikawa T, Izumi H, Kawarasaki T, Miyoshi N, Tanimoto A: Reference Values of Hematological and Biochemical Parameters for the World Smallest Microminipigs. J Vet Med Sci, 2012; 74: 933-936","DOI":"10.1292\/jvms.11-0571"},{"key":"19","unstructured":"19) Miura N, Kawaguchi H, Nagasato T, Yamada T, Ito T, Izumi H, Shameshima H, Miyoshi N, Tanimoto A, Maruyama I: Coagulation activity and white thrombus formation in the microminipig. In Vivo, 2013; 27: 357-361"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lichtman AH, Clinton SK, Iiyama K, Connelly PW, Libby P, Cybulsky MI: Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol, 1999; 19: 1938-1944","DOI":"10.1161\/01.ATV.19.8.1938"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gordon DJ, Rifkind BM: High-density lipoprotein--the clinical implications of recent studies. N Eng J Med, 1989; 321: 1311-1316","DOI":"10.1056\/NEJM198911093211907"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Quig DW, Zilversmit DB: High density lipoprotein metabolism in a rabbit model of hyperalphalipoproteinemia. Atherosclerosis, 1989; 76: 9-19","DOI":"10.1016\/0021-9150(89)90189-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Brinton EA, Eisenberg S, Breslow JL: A low-fat diet decreases high density lipoprotein(HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest, 1990; 85: 144-151","DOI":"10.1172\/JCI114405"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setala K, Walsh A, Breslow JL: Dietary fat increases high density lipoprotein(HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. J Clin Invest, 1993; 91: 1665-1671","DOI":"10.1172\/JCI116375"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Greeve J, altkemper I, Dieterich JH, Greten H, Windler E: Apoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res, 1993; 34: 1367-1383","DOI":"10.1016\/S0022-2275(20)36966-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Greeve J, Jona VK, Chowdhury NR, Horwitz MS, Chowdhury JR: Hepatic gene transfer of the catalytis subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits. J Lipid Res, 1996; 37: 2001-2017","DOI":"10.1016\/S0022-2275(20)37565-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hardtmann DA, Pullinger CR, Hamilton RL, Kane JP, Malloy MJ: Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J Clin Invest, 1991; 88: 1722-1729","DOI":"10.1172\/JCI115490"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science, 1986; 232: 34-47","DOI":"10.1126\/science.3513311"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Goedeke L, Fernandez-Hernando C: Regulation of cholesterol homeostasis. Cell Mol Life Sci, 2012; 69: 915-930","DOI":"10.1007\/s00018-011-0857-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Rudling M: Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res, 1992; 33: 493-501","DOI":"10.1016\/S0022-2275(20)41615-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Rudling M, Angelin B, Stahle L, Reihner E, Sahlin S, Olivecrona H, Bjorkhem I, Einarsson C: Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3- methylglutaryl Coenzyme A reductase, and cholesterol 7\u03b1-hydroxylase mRNAs in human liver. J Clin Endocrinol Metab, 2002; 87: 4307-4313","DOI":"10.1210\/jc.2002-012041"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kong WJ, Liu J, Jiang JD: Human low-density lipoprotein receptor gene and its regulation. J Mol Med, 2006; 84: 29-36","DOI":"10.1007\/s00109-005-0717-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lammert F, Wang DQ: New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology, 2005; 129: 718-734","DOI":"10.1016\/j.gastro.2004.11.017"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Redinger RN: Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis. J Lab Clin Med, 2003; 142: 7-20","DOI":"10.1016\/S0022-2143(03)00088-X"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Betters JL, Yu L: NPC1L1 and cholesterol transport. FEBS Lett, 2010; 584: 2740-2747","DOI":"10.1016\/j.febslet.2010.03.030"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Pramfalk C, Jiang ZY, Cai Q, Hu H, Zhang SD, Han TQ, Eriksson M, Parini P: HNF1\u03b1 and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res, 2010; 51: 1354-1362","DOI":"10.1194\/jlr.M900274-JLR200"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Alrefai WA, Annaba F, Sarwar Z, Dwivedi A, Saksena S, Singla A, Dudeja PK, Gill RK: Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. Am J Physiol Gastrointest Liver Physiol, 2007; 292: G369-G376","DOI":"10.1152\/ajpgi.00306.2006"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Yamashita S, Hirano K, Sakai N, Matsuzawa Y: Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta, 2000; 1529: 257-275","DOI":"10.1016\/S1388-1981(00)00164-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Rosenson RS, Brewer Jr HB, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, vanCharvet LY: Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation, 2012; 125: 1905-1919","DOI":"10.1161\/CIRCULATIONAHA.111.066589"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Guyard-Dangremont V, Desrumaux C, Gambert P, Lallemant C, Lagrost L: Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Regulation to atherogenesis susceptibility. Comp Biochem Physiol B Biochem Mol Biol, 1998; 120: 517-525","DOI":"10.1016\/S0305-0491(98)10038-X"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Hogarth CA, Roy A, Ebert DL: Genomic evidence for the absence of a functional cholesterol ester transfer protein gene in mice and rats. Comp Biochem Physiol B Biochem Mol Biol, 2003; 135: 71-81","DOI":"10.1016\/S1096-4959(03)00046-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Marotti KR, Castle CK, Boyle TP, Lin AH, Murry RW, Melchior GW: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature, 1993; 364: 73-75","DOI":"10.1038\/364073a0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Zuckerman SH, Evans GF, Schekm JA, Eacho PI, Sandusky G: Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human apo B100 x CETP transgenic mice. Arterioscler Thromb Vasc Biol, 1999; 19: 1476-1483","DOI":"10.1161\/01.ATV.19.6.1476"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Hayek T, L Massuci-Magoulas, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR: Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholestery ester transfer protein transgene. J Clin Invest, 1995; 96: 2071-2074","DOI":"10.1172\/JCI118255"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) F\u00f6ger B, Chase M, Amar MJ, Vaisman BL, Shamburek RD, Paigen B, Fruchart-Najib J, Paiz JA, Koch CA, Hoyt RF, Brewer HB Jr, Santamarina-Fojo S: Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem, 1999; 274: 36912-36920","DOI":"10.1074\/jbc.274.52.36912"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Gardner CD, Fortmann SP, Krauss RM: Association of small low density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA, 1996; 276: 875-881","DOI":"10.1001\/jama.1996.03540110029028"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despr\u00e9s JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Qu\u00e9bec Cardiovascular Study. Circulation, 1997; 95: 69-75","DOI":"10.1161\/01.CIR.95.1.69"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ: Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol, 2002; 90: 689-696","DOI":"10.1016\/S0002-9149(02)02591-2"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ: Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med, 2004; 350: 1505-1515","DOI":"10.1056\/NEJMoa031766"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Ishigami M, Yamashita S, Sakai N, Arai T, Hirano K, Hiraoka H, Kameda-Takemura K, Matsuzawa Y: Large and cholesterylester-rich high density lipoproteins in cholesteryl ester transfer protein deficienct can not protect macrophages from cholesterol accumulation induced by acetylated low density lipoproteins. J Biochem, 1994; 116: 257-262","DOI":"10.1093\/oxfordjournals.jbchem.a124516"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ: Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol, 2000; 20: 1323-9132","DOI":"10.1161\/01.ATV.20.5.1323"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Brousseau ME, O\u2019Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ: Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol, 2002; 22: 1148-1154","DOI":"10.1161\/01.ATV.0000024566.57589.2E"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Yamashita S, Hui DY, Wetterau JR, Sprecher DL, Harmony JAK, Matsuzawa Y, Tarui S: Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem Biophys Res Commun, 1990; 170: 1346-1351","DOI":"10.1016\/0006-291X(90)90542-U"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda-Takemura-K, Hayashi K, Matsuzawa Y: Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol, 1995; 15: 1849-5618","DOI":"10.1161\/01.ATV.15.11.1849"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Hirano K, Yamashita S, Sakai N, Arai T, Yoshida Y, Nozaki S, Kameda-Takemura K, Matsuzawa Y: Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann N Y Acad Sci, 1995; 748: 599-602","DOI":"10.1111\/j.1749-6632.1994.tb17370.x"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators: Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med, 2012; 367: 2089-2099","DOI":"10.1056\/NEJMoa1206797"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Peterson J, Bengtsson-Olivecrona G, Olivecrona T: Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochim Biophys Acta., 1986; 878: 65-70","DOI":"10.1016\/0005-2760(86)90344-9"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Mezdour H, Jones R: Dengremont C, Castro G, Maeda N: Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem, 1997; 272: 13570-13575","DOI":"10.1074\/jbc.272.21.13570"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Dichek HL, Qian K, Agrawal N: Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol, 2004; 24: 1696-1702","DOI":"10.1161\/01.ATV.0000135981.61827.9d"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q: Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA, 1994; 91: 8724-8728","DOI":"10.1073\/pnas.91.18.8724"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:00:32Z","timestamp":1647126032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/21\/3\/21_21246\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.21246","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}